V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008320 | 310005491 | 1.5 | 71 | Curative (C) | null | 2016-10-03 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 310006343 | CARBOPLATIN + DOCETAXEL |
| 310008321 | 310005491 | 1.53 | 61.1 | Palliative (P) | 2015-09-24 | 2015-09-25 | CERITINIB | 2 | Y | 310006343 | HYDROXYCARBAMIDE |
| 310008322 | 310005492 | 1.75 | null | Curative (C) | 2014-04-16 | 2014-07-19 | Alemtuzumab | 02 | N | 310006677 | TRASTUZUMAB |
| 310008323 | 310005492 | null | 90.5 | Palliative (P) | 2013-06-06 | 2013-06-06 | BCG Intravesical | N | N | 310006677 | CISPLATIN + PEMETREXED |
| 310008324 | 310005495 | null | null | Palliative (P) | 2018-12-15 | 2018-12-20 | ECF | N | N | 310006958 | IVA |
| 310008325 | 310005496 | 0 | null | Curative (C) | 2017-08-18 | 2017-08-18 | Bevacizumab+Carbo+Gemcitabine | 2 | N | 310006958 | EVEROLIMUS |
| 310008326 | 310009994 | 1.68 | 58 | null | null | 2015-10-06 | AXITINIB | N | N | 310007069 | DOXORUBICIN |
| 310008327 | 310005500 | null | 0 | Palliative (P) | 2015-11-19 | 2015-11-19 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 310007470 | DOXORUBICIN |
| 310008328 | 310005502 | 1.85 | 77 | Palliative (P) | 2013-10-16 | 2013-10-20 | Erlotinib | N | N | 310007470 | ABIRATERONE |
| 310008329 | 310005504 | null | null | Curative (C) | 2016-10-06 | 2016-11-12 | Gemcitabine + Treosulfan (iv) | 02 | null | 310007558 | ICE |
| 310008330 | 310005507 | null | 75.7 | Curative (C) | 2014-07-03 | 2014-11-08 | FEC 60 or 75 | N | null | 310007946 | AZACITIDINE |
| 310008331 | 310005507 | null | null | Curative (C) | 2018-02-26 | 2018-04-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 310007946 | FLUDARABINE + MELPHALAN |
| 310008332 | 310005507 | 1.6 | 52 | Curative (C) | null | 2016-02-15 | Cisplatin + Paclitaxel | null | null | 310007946 | MITOXANTRONE + PACLITAXEL |
| 310008333 | 310005507 | 1.74 | 60.4 | Palliative (P) | 2016-03-06 | 2016-04-02 | PEG INTERFERON | null | null | 310007946 | VEMURAFENIB |
| 310008334 | 310005507 | 0 | 63.9 | Curative (C) | 2016-09-07 | 2016-09-07 | LANREOTIDE | N | N | 310007946 | DACARBAZINE |
| 310008335 | 310005508 | null | 52.3 | Curative (C) | 2017-12-06 | 2017-12-22 | PLUTO TRIAL | 02 | N | 310009263 | THALIDOMIDE |
| 310008336 | 310005509 | 1.66 | 68.38 | Palliative (P) | 2015-06-29 | 2015-07-08 | Trabectedin | 02 | N | 310009636 | FEC |
| 310008337 | 310005509 | null | 75.7 | Palliative (P) | 2016-10-19 | 2016-10-19 | Azacitidine | null | null | 310009636 | BCG |
| 310008338 | 310005511 | 1.5 | 70.8 | null | 2018-09-21 | 2018-09-24 | ICE + GCSF | 02 | N | 310010646 | EOX |
| 310008339 | 310008439 | 1.76 | 82.8 | Palliative (P) | 2014-05-23 | 2014-07-31 | ECX | 2 | N | 310010646 | DABRAFENIB |
| 310008340 | 310005512 | null | 140 | Palliative (P) | 2017-05-07 | 2017-05-08 | Oxaliplatin + Modified de Gramont | N | N | 310010718 | TOPOTECAN |
| 310008341 | 310005515 | 1.7 | 79 | Not known (9) | 2015-02-26 | 2015-05-30 | Irinotecan + Modified De Gramont | 02 | N | 310010912 | CETUXIMAB + RT |
| 310008342 | 310005516 | 1.9 | 81.5 | Curative (C) | null | 2015-07-30 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | 01 | N | 310011046 | IVA |
| 310008343 | 310005516 | 1.59 | 64.5 | Curative (C) | 2015-07-10 | 2015-08-20 | DHAP | N | null | 310011046 | BCG |
| 310008344 | 310005517 | 1.57 | null | Palliative (P) | 2015-09-09 | 2015-09-13 | Dacarbazine | N | N | 310011231 | RMS 2005 TRIAL |
| 310008345 | 310005522 | 1.68 | 69.6 | Curative (C) | null | 2017-02-13 | Dacarbazine | 02 | N | 310011253 | CARBOPLATIN + RT |
| 310008346 | 310008444 | null | 96.8 | Not known (9) | 2014-06-26 | 2014-06-28 | Vinblastine | 02 | N | 310011811 | HYDROXYCARBAMIDE |
| 310008347 | 310008444 | 1.65 | 85 | Palliative (P) | 2018-04-29 | 2018-05-01 | Methotrexate 25-50mg/m2 iv 7day | 2 | N | 310011811 | BENDAMUSTINE |
| 310008348 | 310005525 | 1.77 | 92.8 | Palliative (P) | 2017-10-17 | 2017-10-26 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 310012201 | DABRAFENIB + TRAMETINIB |
| 310008349 | 310005525 | 1.68 | 80.1 | Not known (9) | 2018-11-25 | 2018-12-30 | Azacitidine | 02 | null | 310012201 | TRABECTEDIN |
| 310008350 | 310005525 | 1.62 | 49 | Palliative (P) | 2016-12-15 | 2016-12-22 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 310012201 | CAPECITABINE |
| 310008351 | 310010006 | 1.76 | 0 | Curative (C) | 2019-02-23 | 2019-02-23 | Methotrexate High Dose (3g/m2) | N | N | 310012353 | CISPLATIN + PEMETREXED |
| 310008352 | 310005527 | 1.76 | 75.6 | Palliative (P) | 2015-10-19 | 2018-11-20 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | N | 310012726 | TEMOZOLOMIDE |
| 310008353 | 310005527 | 1.59 | 85.6 | Neo-adjuvant (N) | 2018-03-18 | 2018-06-23 | CARBOPLATIN + RT | N | N | 310012726 | ALEMTUZUMAB |
| 310008354 | 310005527 | 1.69 | 61.5 | Adjuvant (A) | 2017-05-10 | 2017-05-13 | NEOSCOPE TRIAL | 2 | N | 310012726 | IVA |
| 310008355 | 310005530 | null | null | Palliative (P) | 2016-08-09 | 2016-08-12 | Trabectedin | N | N | 310012991 | CAPECITABINE + RT |
| 310008356 | 310005530 | 1.68 | 61.5 | null | null | 2017-07-06 | CYCLO + ETOPOSIDE + NELARABINE | 1 | null | 310012991 | BCG |
| 310008357 | 310005532 | 1.6 | 101.8 | Palliative (P) | 2014-07-19 | 2014-07-20 | MITOMYCIN | 02 | N | 310013090 | GEMCITABINE + VINORELBINE |
| 310008358 | 310005533 | 1.96 | 61.9 | Curative (C) | 2017-08-27 | 2017-09-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 310013116 | CETUXIMAB + RT |
| 310008359 | 310008450 | 1.54 | 71 | Palliative (P) | 2014-05-12 | 2014-05-14 | Irinotecan + Modified De Gramont | N | N | 310013139 | METHOTREXATE HIGH DOSE |
| 310008360 | 310005535 | null | 80 | null | 2016-02-12 | 2016-02-17 | ICE | N | null | 310013139 | TOPOTECAN |
| 310008361 | 310005537 | 1.72 | 66.5 | Curative (C) | 2014-11-16 | 2014-11-23 | BCG Intravesical | N | N | 310013547 | BCG |
| 310008362 | 310005538 | 1.8 | null | Curative (C) | 2016-11-13 | 2017-01-13 | CTD Attenuated (Thalidomide 100mg) | N | N | 310013660 | METHOTREXATE |
| 310008363 | 310008453 | 1.64 | 0 | Palliative (P) | 2017-11-15 | 2017-11-16 | Ralitrexed | 2 | N | 310013706 | DABRAFENIB |
| 310008364 | 310008453 | 1.8 | 54.8 | Palliative (P) | 2016-05-26 | 2016-09-01 | INCA TRIAL | N | N | 310013706 | CAPECITABINE |
| 310008365 | 310005539 | 1.66 | 78.4 | Palliative (P) | 2018-05-07 | 2018-05-08 | Cyclophosphamide Fludarabine (Oral) | 02 | N | 310014050 | TOPOTECAN |
| 310008366 | 310005540 | 1.62 | 54.7 | null | null | 2018-05-09 | ICON8B TRIAL | null | null | 310014077 | CAPECITABINE + CISPLATIN |
| 310008367 | 310005541 | null | 124.9 | Palliative (P) | null | 2019-05-04 | Gemcitabine + Oxaliplatin | 02 | N | 310014132 | BENDAMUSTINE |
| 310008368 | 310005542 | null | 58.2 | Palliative (P) | 2018-08-15 | 2018-08-01 | PEG INTERFERON | N | N | 310014344 | GEMCITABINE + OXALIPLATIN |
| 310008369 | 310005542 | 1.78 | 68 | Palliative (P) | 2017-05-12 | 2017-05-13 | DOXORUBICIN | N | N | 310014344 | DACARBAZINE |